{"id":816612,"date":"2025-02-24T07:55:57","date_gmt":"2025-02-24T12:55:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/"},"modified":"2025-02-24T07:55:57","modified_gmt":"2025-02-24T12:55:57","slug":"apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/","title":{"rendered":"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WALTHAM, Mass., Feb.  24, 2025  (GLOBE NEWSWIRE) &#8212; Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS) today announced that the company will present at the TD Cowen 45<sup>th<\/sup> Annual Health Care Conference on Monday, March 3, 2025, at 10:30 a.m. ET.<\/p>\n<p>The live conference webcast will be posted on the \u201cEvents and Presentations\u201d page of the \u201cInvestors and Media\u201d section of the company\u2019s\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=52A1C2dba_Rst6U6Hf54Y1jUFj_GESTx_aCoWTea60rkU6Mel1zQRjgI9wN_5DKTCkhNY4nSX_g2DjS-4TpcZ8KavvW3tD5WWiRQgicJTX7hbioHBqKLuGYSdyVFrkyHo8fFBXzn_0_ASOrK4oXntl6ehDZdapN6iPv6qBgRsV6m323-Wt3bSqFzUGNQxgj6jfGYw_NXGkCe2CuO0hxEmlnBB1gf1SOO-dHOyW7llgg=\" rel=\"nofollow\" target=\"_blank\">website<\/a>. A replay of the webcast will be available for approximately 90 days following the event.<\/p>\n<p>\n        <strong>About Apellis<\/strong><br \/>\n        <br \/>Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two approved medicines targeting C3. These include the first-ever therapy for geographic atrophy, a leading cause of blindness around the world. We believe we have only begun to unlock the potential of targeting C3 across many serious diseases. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eduNdNFN10939oisWZ3a4GuKrq1-v6LZL6CTYLXQwvWgYtoRWKiJfeaNO0R87YW-PHGreBAH4Hrpl_nLXAIb3X0K9cVcOWnWNUahtqRw2dNgm_cIhISvuhlir4x1mKutHyerCLqgW_NDAbXLn3wQWfhtcXAtupMYB-OgbEhaD7NQ5Qoq4ba31GXrnLRtnvS3ZLqjMP-16820jb-Og22ru8LPouJJU9Ol00lyCUWd1z5lZC6i_zzmQ0Bmtjahbsb0FoBsNScmV7uDo5w7fdUYT6a9I-m5PO-praeR9TxXjhHA_QH2ewfE2v-k6q4ASa6KZXlZL0jsmb7YxuOVN-Z1Mj5EjOJsx-idAEHzxtEZiRXS-2rePqtubsdM4aMpN1qOwkYV8LbAtQKHrKjBZNNb6F2fudcTG8HHsvdK33OJ6HixEAhDbEGvSBI_3lRYF4xebwt4urYr3ic6SpuEWrNTSzFcpOk8IEO9VRSk2b-Rqk84VLRAL5WYtUx3hXVpadILfMNKmJG9eJcO4Q7zQpvSF5jmvIwn--GRMUtm9t2leWkR-hmRhm41d0Suuxqz8KNg526Mx216sqVfEoYPfJueZGY36dbX6CDsb70_uqavpIAq2qo9Z2Z8ZLC0gvQsY6XMVSmK7k4b9UxDWOpxS4khhLfcLFmpElk8nFFubtEss3JyNTDAPPd7XxGfP-uUnOsLCwvwJIw1X-nuR7VM2ERnYa4aZNohRh-BgFfks0OB1xRMZ8QcbC0ZbPSTK2-d5rd8Yl8vZTsG3gP_7dWcwH5TiVH32nkh0-y4_hdd5kXdfP1O_MAa2iEcRa2OUXos8GI4C9FeL8IEUARcCUWu84ftI4Kn2egfGl_sJRov-Fe2GVtma-PfojOEqdTcr_Ky0RW1ggU6AD5n4Z_7CVkkDJIvFlpvsoo5d5rElKfhSzAWoojxGnK__OlwE4zqcKmgf7GZpigaecumP9J-KboKsBTNdgX3jp7W0StC3GD5lNLYBlg77WU-xXRvQmCJyDyUBig8mhA-RRl_aZyopTAyDEJyKXGeL_DcVk-pfog_iFSaWCnOeWb47TDQ84GaRskK1pw6\" rel=\"nofollow\" target=\"_blank\">http:\/\/apellis.com<\/a>\u00a0or follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zdGSyyXs6zyXE-pJl-3TPeLaAfs4f_BQGFLkLVGKqI7559YIppfm9HbDfLCc-zdf29D9zEBGjJm-rIh6yZcvn3XqQq5_sdB45Itkv264jdij7hBJ_3xDssBXYsZfMHCQNXmg8goxb7jspJaFZoTRs4NCwUASnPsHSvbV4dbx8ALfGOgS-zcBdVbAVZSKt7jfdnF8wzMh1-Sv-GLg-p0LjC4ZbigbBQmL4dnVjtHzgxuKaC85eKl150IoYuIw4n2LQxlQsV5pDq5VoPuW3_RcjlmwsGZ3KIZ-ZUWKHlurAMy8jrWR_6sg82u2lGsAtyAeuvQlwIOYa1wys6vAzylHm4qoQr_nm3qlO_APtlcTWi_tD5bbHuzuByetfSWvJE6-GC67qpsL1ViEXz7Y-IFF5HGcVlmT7-Tc5eY7M1z0---ew6cYGKIGKkiMZVVCxROAyeW0W2tHOcTppPnIGahlSuJ20vqgjk3OYDNKBIySfjXsLIrQCMb904k_Cs0_4U_sESXY-hpYKpgOcs5_Gof5rEWlh8eBFsr4l2nF697802G5epqi7JGEW3t4dSnioOBmiULTWwdtQLtC7qWVPYUCEIuOgBKnqvHJykQ8dElytJNrJme1gRDuOI3plhgyy5S__RP082zH6prkWrg3pGZzS57hGIG8gJMiVQZGdDY_8tjEpQl_S1jZsQQeKrcNBpXpuUSbv4c0lPnpBK7uznKszmeNel8tY4X5Nszr2lCeDdW75tUkqeunjHijsxRy9ICtVl6VIX2bVYERape2h0_LBOci2ZjmekIUGHdGYr6X0vNx__3K2MDsLjwCDAtKiA5t6YuMaG9kWXKUUTO5mb3woI4wU9w-AekRAJNARZuJVIw=\" rel=\"nofollow\" target=\"_blank\">Twitter<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pyN_jFndmETMkMYuUU2uEPAbF8a02H8TceY3nMry9u_IFRfIX4kTezYPAeBq_up1TYIuwFEXSIm7UZd1AXZyTsVsQhPu-Ezb-b1SnKw1SgU2lFBn0aZUAxexvR84suhYL7RgCuqjtBLjhxo3hSwqPRY68eayH5ZgEYafBlvM0lNnoiepzwUiBvk67UqXLTXB8gOIkw-82ojiumMh1gaBOVPKMjsS8Qnr5Lb0BXAxOiyBrntKpED6VXr-ZkLyiIeuX3SwwsSuU1GvIh7JA1YP56G2dkQKzSna9yj3FNM2IcY2agdZU-tSIArK65PGW7RwVOj_hdRAOzUB4yMJgccq34Jk19TjV8-nDaGK8zBVrLIhtmem7uR0g9L7LuRDx6otRN5KDQytdYSu6OKly6S2I32Wfj4obScRPHZieEnPe8faI8c0osycPr_2hodKqn0xcdQ2HMuJ5pPLi7rqoFHBDPDd9-5E7sBG8c6svpgXTu4WTFM7nUxX6RhphapEG6g5mVJVoXCy1yuRssDVBNdJjHLt9WyIEm3kLqSc14pzbbGnY46nuF34ZPeoPxCFoCP5xCrjOwiLAS5XKFg6JtgFK_t4O_VBJWNPfMoff3tdxW5d1Wc87wTJocHYxbxDA0_0uUn7g3Bc01ly34xOTNcY58-1SpvEY6MpgnuMmcY6jnQAdx32FYaxZ8AA9u8K0-dB\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong>\u00a0<br \/>Meredith Kaya\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y-vGP9oq-jLFrmpfTskiOm7a8fGfj6i0U8dRUJTBM7Hhe9sWcRCMYcg4xZAzdNK1gbqFMTBpWU_hG1v7GfgvDkVA-FYO3nQjFXii-Y10itoq6P2J4sInIxZsQvF4bmGcQAPJXbm-7TIiwMRrbqz28mz43_WUY3Bg1d0JtjswPEKZN7vzkig_Cg0hTmaLAyRx15pWLIC93GoeiHJ2dpBVvEOx3ZafgBvbWLKU28HqOR-BiA6IjD2K8xB4riKSRrbjWdgFQmq5F59m3-cPXNuqsA==\" rel=\"nofollow\" target=\"_blank\">meredith.kaya@apellis.com<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NKBu43cPgOskKlVI29LZ1tfsOHO0K0KnhTIX7FjF25BFPFDZfEo8j0w82NuqtcwHzvMjYLdlV2ftv_HfMDfGkxnL3GWDvRolMpKNb6W_U4-0ae5Ql0s2kXYDLKCnnrS5hbF-EjYj9zMq5jRTHXU1Qk5EUvcaGXeqxjmzkclz9NK1uv7sWCuNf2f1MY2xUaLk1UaoEjIeiAx90wY4ypZJ8ORwuZttLnNqv519Vd3JLMZazJQ1H51tHxIuHAlFgVnhdSx7fWa31sH50nWr8wlMFjNGpeje79PSebnvyU6a9EJjpq-Mg8_3jSqGOA33FbfSsRiwk7Tr56EW4FIuE2iL_klwNZ-VF4iavY8ww0JRlRtvDUn2kJjHerI-qMKrz32_\" rel=\"nofollow\" target=\"_blank\"><br \/><\/a>617.599.8178<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MjA1NTllMWQtZDlhZC00NTFlLThlYmUtYTE3YWE2YTNmMjgwLTEwMzE1OTg=\/tiny\/Apellis-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) &#8212; Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS) today announced that the company will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 10:30 a.m. ET. The live conference webcast will be posted on the \u201cEvents and Presentations\u201d page of the \u201cInvestors and Media\u201d section of the company\u2019s\u00a0website. A replay of the webcast will be available for approximately 90 days following the event. About Apellis Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816612","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) &#8212; Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS) today announced that the company will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 10:30 a.m. ET. The live conference webcast will be posted on the \u201cEvents and Presentations\u201d page of the \u201cInvestors and Media\u201d section of the company\u2019s\u00a0website. A replay of the webcast will be available for approximately 90 days following the event. About Apellis Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two &hellip; Continue reading &quot;Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-24T12:55:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference\",\"datePublished\":\"2025-02-24T12:55:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/\"},\"wordCount\":190,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/\",\"name\":\"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=\",\"datePublished\":\"2025-02-24T12:55:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/","og_locale":"en_US","og_type":"article","og_title":"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - Market Newsdesk","og_description":"WALTHAM, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) &#8212; Apellis Pharmaceuticals,\u00a0Inc. (Nasdaq: APLS) today announced that the company will present at the TD Cowen 45th Annual Health Care Conference on Monday, March 3, 2025, at 10:30 a.m. ET. The live conference webcast will be posted on the \u201cEvents and Presentations\u201d page of the \u201cInvestors and Media\u201d section of the company\u2019s\u00a0website. A replay of the webcast will be available for approximately 90 days following the event. About Apellis Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that combines courageous science and compassion to develop life-changing therapies for some of the most challenging diseases patients face. We ushered in the first new class of complement medicine in 15 years and now have two &hellip; Continue reading \"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-24T12:55:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference","datePublished":"2025-02-24T12:55:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/"},"wordCount":190,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/","name":"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=","datePublished":"2025-02-24T12:55:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2Mjc4MyM2NzYwOTk4IzIwMjAwMjY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/apellis-pharmaceuticals-to-present-at-the-td-cowen-45th-annual-health-care-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816612","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816612"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816612\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816612"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816612"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816612"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}